NCT02329184View on ClinicalTrials.gov

Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

MYK-461

Trial Locations (7)

27710

Durham

37232

Nashville

49007

Kalamazoo

85259

Scottsdale

90630

Cypress

94305

Stanford

02111

Boston

Sponsors

Lead Sponsor

MyoKardia, Inc.
All Listed Sponsors
lead

MyoKardia, Inc.

INDUSTRY